Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.890
+0.260 (9.89%)
May 28, 2026, 3:36 PM EDT - Market open
Equillium Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
182.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 41.10M | 5.01M | 13.89% |
| Dec 31, 2023 | 36.08M | 20.33M | 128.97% |
| Dec 31, 2022 | 15.76M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Q32 Bio | 53.74M |
| Precision BioSciences | 45.07M |
| MediWound | 14.48M |
| Korro Bio | 3.84M |
| Milestone Pharmaceuticals | 1.78M |
EQ News
- 4 hours ago - Equillium price target raised to $7 from $6 at Raymond James - TheFly
- 9 hours ago - Leerink upgrades Equillium on ‘supportive’ ulcerative colitis data - TheFly
- 9 hours ago - Equillium upgraded to Outperform from Market Perform at Leerink - TheFly
- 1 day ago - Equillium Transcript: Status update - Transcripts
- 1 day ago - Equillium Slides: Status update - Filings
- 7 days ago - Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis - GlobeNewsWire
- 14 days ago - Equillium Slides: Corporate presentation - Filings
- 14 days ago - Equillium reports Q1 EPS (6c), consensus (4c) - TheFly